See key milestones in the history of C-Path.

Dedicated to bringing scientists from the FDA, industry, and academia together

To improve the path for innovative new drugs,
diagnostic tests and devices to reach patients in need.

Our Timeline

Jan 23, 2012

C‐Path receives approval from the European Medicines Agency (EMA) for imaging biomarker as a qualified measure to select patients with early stage cognitive impairment for Alzheimer’s disease clinical trials.

Sep 9, 2010

With support and funding from the Polycystic Kidney Disease Foundation, C‐Path launches Polycystic Kidney Disease Outcome Consortium (PKDOC).

Mar 24, 2010

C‐Path launches Critical Path to TB Drug Regimens (CPTR).

Jul 1, 2009

C‐Path launches Coalition Against Major Diseases (CAMD) as a consortium with pharmaceutical companies, patient groups, FDA and NIH to address clinical trial needs in neurological diseases.

Oct 18, 2007

Arizona’s Governor Janet Napolitano honors C‐Path with an “Arizona Innovation Award” to recognize its groundbreaking approach to speeding the development of safe, innovative medicines and medical devices.

Sep 27, 2007

President George W. Bush signs bill that authorizes FDA to create “Critical Path Public/Private Partnerships.” The first (and most successful) of these is the collaboration between the FDA and C‐Path.

Jun 7, 2007

C‐Path hosts ribbon‐cutting ceremony at the Library of Congress to officially announce opening of its Rockville, Maryland office.

Dec 10, 2005

C‐Path hosts Tucson ribbon‐cutting ceremony to officially launch institute.

Jul 1, 2005

C‐Path begins first fiscal year with six full‐time employees.

Nov 1, 2004

State of Arizona awards C-Path a planning grant. C-Path files articles of non-profit incorporation.